For Southeast Asian manufacturers looking to sell on Alibaba.com and reach global healthcare buyers, understanding the FDA regulatory framework is non-negotiable. The U.S. Food and Drug Administration (FDA) regulates medical device fasteners under a comprehensive system that ensures patient safety and product efficacy.
FDA 21 CFR 174-179 forms the core regulatory framework for materials that come into contact with food and medical devices. Specifically, 21 CFR 177 addresses polymers and plastic components commonly used in medical fasteners, while 21 CFR 175.300 covers epoxy resins and prohibits bisphenol A (BPA) in infant formula packaging [1].
For medical device fasteners, manufacturers must navigate two primary certification pathways:
FDA Certification Pathways for Medical Fasteners
| Certification Type | Applicable Standards | Testing Requirements | Documentation Needed | Timeline |
|---|---|---|---|---|
| FDA 21 CFR 177 | Polymers for food/medical contact | Migration testing, extractables analysis | Material safety data sheets, test reports | 3-6 months |
| ISO 10993 Biocompatibility | ISO 10993-1, -5, -10 | Cytotoxicity, sensitization, irritation | Full biocompatibility test battery | 6-12 months |
| GRAS Certification | Generally Recognized As Safe | Literature review, expert panel | Scientific literature compilation | 2-4 months |
| TOR Exemption | Threshold of Regulation | Migration <1.5 μg/kg/day | Migration study data | 1-3 months |
Biocompatibility testing under ISO 10993 is often required for fasteners used in surgical instruments, implantable devices, or any application where the fastener contacts human tissue. The testing battery typically includes cytotoxicity, sensitization, and irritation studies.
The devil you know is better than the devil you don't. BPA replacement chemicals are largely untested, and we're seeing growing skepticism about 'BPA-free' claims without third-party verification [2].
